Subscribe
bee32
bee32 / iStockphoto.com
4 January 2018Americas

Native American tribe seeks information on PTAB judges

A Native American tribe that has signed a patent deal with Allergan has requested information on the Patent Trial and Appeal Board (PTAB) judges overseeing inter partes reviews (IPRs) involving the tribe.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Native American tribe hits back at Mylan in PTAB filing
24 October 2017   The Saint Regis Mohawk Tribe, the owner of dry eye disease treatment Restasis (cyclosporine ophthalmic emulsion), has hit back at Mylan for questioning its sovereign immunity.
Americas
PTAB dismisses Native American tribe information request
8 January 2018   The Patent Trial and Appeal Board has denied an information request by a Native American tribe, deeming it improper for a number of reasons.
Big Pharma
Allergan tries to escape Restasis IPRs
10 January 2018   Allergan is attempting to remove itself from a series of inter partes reviews focused on dry eye treatment Restasis (cyclosporine ophthalmic emulsion).


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Americas
Native American tribe hits back at Mylan in PTAB filing
24 October 2017   The Saint Regis Mohawk Tribe, the owner of dry eye disease treatment Restasis (cyclosporine ophthalmic emulsion), has hit back at Mylan for questioning its sovereign immunity.
Americas
PTAB dismisses Native American tribe information request
8 January 2018   The Patent Trial and Appeal Board has denied an information request by a Native American tribe, deeming it improper for a number of reasons.
Big Pharma
Allergan tries to escape Restasis IPRs
10 January 2018   Allergan is attempting to remove itself from a series of inter partes reviews focused on dry eye treatment Restasis (cyclosporine ophthalmic emulsion).

More on this story

Americas
Native American tribe hits back at Mylan in PTAB filing
24 October 2017   The Saint Regis Mohawk Tribe, the owner of dry eye disease treatment Restasis (cyclosporine ophthalmic emulsion), has hit back at Mylan for questioning its sovereign immunity.
Americas
PTAB dismisses Native American tribe information request
8 January 2018   The Patent Trial and Appeal Board has denied an information request by a Native American tribe, deeming it improper for a number of reasons.
Big Pharma
Allergan tries to escape Restasis IPRs
10 January 2018   Allergan is attempting to remove itself from a series of inter partes reviews focused on dry eye treatment Restasis (cyclosporine ophthalmic emulsion).

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility